מחקר

מאמרים נבחרים על דיכאון

Nitzan U, Chalamish Y, Krieger I, Erez HB, Braw Y, Lichtenberg P.

Suggestibility as a predictor of response to antidepressants:

A preliminary prospective trial. J Affect Disord. 2015; 24(185):8-11.


Shahaf G, Yariv S, Bloch B, Nitzan U, Segev A, Reshef A, Bloch Y.                         

A Pilot Study of Possible Easy-to-Use Electrophysiological Index for Early Detection of Antidepressive Treatment Non-Response.                                                                     

Front Psychiatry. 2017; 8:128.


Nitzan U., Hecht M., Yarnitsky Y., Levkovitz Y. 

Somatic pain modulation and its role in typifying the dimension of pain in depression. European Neuropsychopharmacology 2014; 24(Suppl. 2) S 475. 


Nitzan U, Hecht M, Braw Y, Maoz H, Levkovitz Y, Yarnitsky D, Granovsky Y,
Bloch Y. Initial Evaluation of Pain Intensity Among Depressed Patients as a Possible Mediator Between Depression and Pain Complaints. 

Front Psychiatry. 2019; 15;10:48. 


Gur S, Talera M, Bormant G, Blattberg D, Nitzan U., Vaknin-Dembinskye A, Brille L, Krivoy A, Weizman A, Hochman E.

Lack of association between unipolar or bipolar depression and serum aquaporin-4 antibodies. 

Brain Behavior and Immunity.

מאמרים נבחרים על חקר הפלסבו בדיכאון

Lichtenberg P (PI), Heresco-Levy U (C), Nitzan U.
Placebo – A biochemical basis to psychosomatic Phenomena 
Harefuah . 2002; 141 (3): 272-7. Hebrew
 
Lichtenberg P, Heresco-Levy U, Nitzan U. 
The Ethics of Placebo in Clinical Practice. 
 J. Med Ethics 2004; 30: 551-554. 

Nitzan U, Lichtenberg P. 
Questionnaire Survey on use of Placebo.  
BMJ 2004; 329(7472): 944–946.  

Nitzan U., Feffer K., Lichtenberg P., Lev-Ran S., Wolfman S, Beker G., Fennig S. 
Consenting not to be informed: a survey on the acceptability of placebo use in the treatment of depression. 
J Nerv Ment Dis. 2013; 201(4): 245-7. 

Nitzan U, Bloch Y, Fennig S. 
Using placebo medications in the clinical setting- an intellectual game or a possible reality? 
Isr J Psychiatry Relat Sci. 2014;51(3):182-7 PubMed PMID: 25618281.

Feffer K, Lichtenberg P, Becker G, Bloch Y, Netzer R, Nitzan U.
A Comparative Study with Depressed Patients on the Acceptability of Placebo Use. 
 Gen Hosp Psychiatry. 2016; 41:53-6. 

Nitzan U., Carmeli G, Braw Y, Kirsch I, Shefet D, Krieger I, Bloch Y, Mendelovitz S, Lichtenberg P. 
Open-Label placebo is efficient among young adults with early onset of major depressive disorder: Results from a randomized controlled trial. 
J Affect Disord 2020; 276: 707-710.

מאמרים נבחרים על הפרעת קשב וריכוז

Maoz H, Aviram S, Nitzan U, Segev A, Bloch Y. 
Association Between Continuous Performance and Response Inhibition Tests in Adults With ADHD. J Atten Disord. 2015; DOI: 10.1177/1087054715584056 

Bloch Y, Aviram S, Neeman R, Braw Y, Nitzan U, Maoz H, Mimouni-Bloch A. 
Methylphenidate mediated change in prosody is specific to the performance of a cognitive task in female adult ADHD patients. World J Biol Psychiatry. 2015 Dec;16(8):635-9.

Shahaf G, Nitzan U, Erez G, Mendelovic S, Bloch Y. 
Monitoring Attention in ADHD with an Easy-to-Use Electrophysiological Index.
Front Hum Neurosci. 2018;12:32.

Gvirts HZ, Lewis YD, Dvora S, Feffer K, Nitzan U, Carmel Z, Levkovitz Y, Maoz H. 
The effect of methylphenidate on decision making in patients with borderline personality disorder and attention-deficit/hyperactivity disorder.
Int Clin Psychopharmacol. 2018; 33(4):233-237. 

מאמרים נבחרים על גרייה מוחית וטיפול בנזעי חשמל

Feffer K, Lapidus K, Braw Y, Bloch Y, Kron S, Netzer R, Nitzan U. 
Factors associated with response after deep transcranial magnetic stimulation in a real-world clinical setting: Results from the first 40 cases of treatment-resistant depression. 
Eur Psychiatry. 2017; 44:61-67.  

Paz Y, Friedwald K, Levkovitz Y, Zangen A, Alyagon U, Nitzan U, Segev A, Maoz H, Koubi M, Bloch Y. 
Randomised sham-controlled study of high-frequency bilateral deep transcranial magnetic stimulation (dTMS) to treat adult attention hyperactive disorder (ADHD): Negative results. 
 World J Biol Psychiatry. 2017; 31:1-6. 

Zukerman N, Yedidya R, Nitzan U. 
Electroconvulsive Therapy Is Safe in a Patient With Punctate Inner Chorodiopathy. 
J ECT. 2020;10.1097/YCT.0000000000000685.  
                                                                                
Maoz H, Nitzan U, Goldwyn Y, Krieger I, Bloch Y. 
When Can We Predict the Outcome of an Electroconvulsive Therapy Course in Adolescents?: A Retrospective Study.